Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abpro Holdings Inc. stock logo
ABP
Abpro
$0.18
+9.4%
$0.24
$0.15
$13.00
$14.28M0.037.27 million shs3.23 million shs
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$1.33
+2.1%
$1.36
$1.09
$4.84
$13.38M0.46485,850 shs73,840 shs
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$0.35
$0.03
$3.17
$3.50M0.497.01 million shs61.02 million shs
NextCure, Inc. stock logo
NXTC
NextCure
$5.30
-2.7%
$5.12
$2.69
$19.20
$14.19M1.2750,468 shs2,456 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abpro Holdings Inc. stock logo
ABP
Abpro
-3.15%-34.88%-33.55%-24.28%+16,279,900.00%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
+3.17%+11.11%+1.56%-23.08%-46.72%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
0.00%0.00%0.00%0.00%-93.46%
NextCure, Inc. stock logo
NXTC
NextCure
-0.91%+10.12%+12.40%-33.43%-66.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abpro Holdings Inc. stock logo
ABP
Abpro
$0.18
+9.4%
$0.24
$0.15
$13.00
$14.28M0.037.27 million shs3.23 million shs
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$1.33
+2.1%
$1.36
$1.09
$4.84
$13.38M0.46485,850 shs73,840 shs
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$0.35
$0.03
$3.17
$3.50M0.497.01 million shs61.02 million shs
NextCure, Inc. stock logo
NXTC
NextCure
$5.30
-2.7%
$5.12
$2.69
$19.20
$14.19M1.2750,468 shs2,456 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abpro Holdings Inc. stock logo
ABP
Abpro
-3.15%-34.88%-33.55%-24.28%+16,279,900.00%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
+3.17%+11.11%+1.56%-23.08%-46.72%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
0.00%0.00%0.00%0.00%-93.46%
NextCure, Inc. stock logo
NXTC
NextCure
-0.91%+10.12%+12.40%-33.43%-66.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abpro Holdings Inc. stock logo
ABP
Abpro
3.00
Buy$4.002,145.93% Upside
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00
N/AN/AN/A
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
2.50
Moderate Buy$0.75∞ Upside
NextCure, Inc. stock logo
NXTC
NextCure
2.67
Moderate Buy$25.50381.59% Upside

Current Analyst Ratings Breakdown

Latest GRTS, NXTC, ABP, and BFRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
NextCure, Inc. stock logo
NXTC
NextCure
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$36.00 ➝ $15.00
7/8/2025
NextCure, Inc. stock logo
NXTC
NextCure
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/1/2025
NextCure, Inc. stock logo
NXTC
NextCure
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$36.00
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abpro Holdings Inc. stock logo
ABP
Abpro
$183K78.02N/AN/A($0.29) per share-0.61
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$33.26K402.25N/AN/A$0.57 per share2.33
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$496K0.00N/AN/A$0.54 per share0.00
NextCure, Inc. stock logo
NXTC
NextCure
N/AN/AN/AN/A$28.06 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abpro Holdings Inc. stock logo
ABP
Abpro
-$7.23MN/A0.00N/AN/AN/A-241.16%N/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.99M-$0.76N/AN/AN/A-195.35%-162.37%N/A
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
-$138.49M-$1.24N/AN/AN/A-910.50%-328.51%-82.53%N/A
NextCure, Inc. stock logo
NXTC
NextCure
-$55.65M-$25.82N/AN/AN/AN/A-106.62%-85.20%11/6/2025 (Estimated)

Latest GRTS, NXTC, ABP, and BFRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Abpro Holdings Inc. stock logo
ABP
Abpro
N/A-$0.04N/A-$0.05N/AN/A
8/13/2025Q2 2025
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A-$0.15N/A-$0.15N/A$0.03 million
8/7/2025Q2 2025
NextCure, Inc. stock logo
NXTC
NextCure
-$4.62-$11.29-$6.67-$11.29N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abpro Holdings Inc. stock logo
ABP
Abpro
N/AN/AN/AN/AN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
N/AN/AN/AN/AN/A
NextCure, Inc. stock logo
NXTC
NextCure
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abpro Holdings Inc. stock logo
ABP
Abpro
N/A
0.15
0.15
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
3.97
3.97
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
1.83
2.54
2.54
NextCure, Inc. stock logo
NXTC
NextCure
N/A
3.71
3.71

Institutional Ownership

CompanyInstitutional Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
23.30%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
48.46%
NextCure, Inc. stock logo
NXTC
NextCure
42.65%

Insider Ownership

CompanyInsider Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
20.80%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
24.72%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
4.61%
NextCure, Inc. stock logo
NXTC
NextCure
17.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abpro Holdings Inc. stock logo
ABP
Abpro
1580.17 million63.49 millionN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
410.08 million7.59 millionNot Optionable
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
190108.57 million111.84 millionOptionable
NextCure, Inc. stock logo
NXTC
NextCure
902.68 million2.20 millionOptionable

Recent News About These Companies

NextCure (NXTC) Q2 Loss Widens 71%
NextCure, Inc. (NXTC) - Yahoo Finance
NextCure tanks as it teams up with Simcere on novel ADC

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abpro stock logo

Abpro NASDAQ:ABP

$0.18 +0.02 (+9.40%)
As of 04:00 PM Eastern

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$1.33 +0.03 (+2.08%)
Closing price 03:59 PM Eastern
Extended Trading
$1.32 0.00 (-0.15%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Gritstone bio stock logo

Gritstone bio NASDAQ:GRTS

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

NextCure stock logo

NextCure NASDAQ:NXTC

$5.30 -0.15 (-2.67%)
Closing price 03:50 PM Eastern
Extended Trading
$5.38 +0.08 (+1.51%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. It has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.